Instrument NameTeva Pharmaceutical Industries ADRInstrument Symbol(TEVA-N)

Instrument ExchangeNYSE

TEVA earnings call for the period ending September 30, 2024.

Teva Pharmaceutical Industries Ltd (TEVA) recently announced robust financial results for Q3 2024, showcasing substantial growth in its generic and innovative product lines. Driven by significant contributions from key products like AUSTEDO and AJOVY, Teva raised its financial forecast for 2024. This performance highlights Teva’s consistent execution of its “Pivot...

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted at specific brain regions and has shown...

TEVA earnings call for the period ending June 30, 2024.

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.

TEVA earnings call for the period ending March 31, 2024.

Teva Pharmaceuticals, the generic drug maker, posted good Q1 results today, reaffirming its forecast for significant free cash flow in 2024. That led to unusual call options activity based on a Barchart report.